{"id":"https://openalex.org/W4416640239","doi":"https://doi.org/10.48089/jfo7688336","title":"GLP-1 Receptor Agonists and Ocular Health: Benefits and Risks","display_name":"GLP-1 Receptor Agonists and Ocular Health: Benefits and Risks","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416640239","doi":"https://doi.org/10.48089/jfo7688336"},"language":"en","primary_location":{"id":"doi:10.48089/jfo7688336","doi":"https://doi.org/10.48089/jfo7688336","is_oa":false,"landing_page_url":"https://doi.org/10.48089/jfo7688336","pdf_url":null,"source":{"id":"https://openalex.org/S4210233215","display_name":"Journal of the Foundations of Ophthalmology","issn_l":"2752-3608","issn":["2752-3608"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Foundations of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Rickvir Sidhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rickvir Sidhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38845195,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.4758000075817108,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.4758000075817108,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.35179999470710754,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.09640000015497208,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9559999704360962},{"id":"https://openalex.org/keywords/eye-health","display_name":"eye health","score":0.8289999961853027},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.8519999980926514},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9470000267028809},{"id":"https://openalex.org/keywords/obesity-treatment","display_name":"obesity treatment","score":0.8399999737739563},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.671999990940094},{"id":"https://openalex.org/keywords/retinal-toxicity","display_name":"retinal toxicity","score":0.3569999933242798},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.3889999985694885},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8644000291824341},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6047000288963318},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5963000059127808},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.5138999819755554},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5090000033378601},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5076000094413757},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4544999897480011},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.44020000100135803},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43700000643730164},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4242999851703644},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4180999994277954},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.3928000032901764},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.38690000772476196},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.37940001487731934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37139999866485596},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.35670000314712524},{"id":"https://openalex.org/C112446052","wikidata":"https://www.wikidata.org/wiki/Q422579","display_name":"Insulin receptor","level":4,"score":0.3131999969482422},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.2955999970436096},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.2815000116825104},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.275299996137619},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2694999873638153}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.48089/jfo7688336","doi":"https://doi.org/10.48089/jfo7688336","is_oa":false,"landing_page_url":"https://doi.org/10.48089/jfo7688336","pdf_url":null,"source":{"id":"https://openalex.org/S4210233215","display_name":"Journal of the Foundations of Ophthalmology","issn_l":"2752-3608","issn":["2752-3608"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Foundations of Ophthalmology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1":[1],"receptor":[2],"agonists":[3],"(GLP-1":[4],"RAs)":[5],"are":[6],"injectable":[7],"or":[8],"oral":[9],"medications":[10],"primarily":[11],"used":[12],"for":[13,20],"type":[14],"2":[15,63],"diabetes":[16],"mellitus":[17],"and,":[18],"increasingly,":[19],"obesity":[21],"management.":[22],"They":[23],"act":[24],"by":[25],"enhancing":[26],"glucose-dependent":[27],"insulin":[28],"secretion,":[29],"suppressing":[30],"glucagon,":[31],"and":[32,40,82,98],"promoting":[33],"satiety,":[34],"leading":[35],"to":[36,68],"improved":[37],"glycaemic":[38],"control":[39],"weight":[41],"loss.":[42],"The":[43],"use":[44,78],"of":[45],"GLP-1":[46],"RAs":[47],"has":[48],"increased":[49],"dramatically":[50],"in":[51,58,66,71,79],"recent":[52],"years.":[53],"For":[54],"example,":[55],"semaglutide":[56],"prescriptions":[57],"the":[59],"US":[60],"rose":[61],"from":[62],"million":[64,70],"monthly":[65],"2021":[67],"5":[69],"2023,":[72],"with":[73,95],"a":[74],"notable":[75],"shift":[76],"toward":[77],"both":[80,96],"diabetic":[81],"nondiabetic":[83],"obese":[84],"populations.":[85],"Their":[86],"impact":[87],"on":[88],"ocular":[89],"health,":[90],"however,":[91],"is":[92],"more":[93],"complex,":[94],"protective":[97],"adverse":[99],"associations":[100],"reported.":[101]},"counts_by_year":[],"updated_date":"2026-07-31T08:31:51.225901","created_date":"2025-11-25T00:00:00"}